zk 112993 has been researched along with lilopristone in 2 studies
| Studies (zk 112993) | Trials (zk 112993) | Recent Studies (post-2010) (zk 112993) | Studies (lilopristone) | Trials (lilopristone) | Recent Studies (post-2010) (lilopristone) |
|---|---|---|---|---|---|
| 25 | 0 | 0 | 49 | 2 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chwalisz, K; Elger, W; Osawa, Y; Shimizu, Y; Yarborough, CP | 1 |
| Altmann, M; Beck, CA; DeMarzo, A; Edwards, DP; Weigel, NL; Zhang, Y | 1 |
2 other study(ies) available for zk 112993 and lilopristone
| Article | Year |
|---|---|
Inhibition of aromatase activity in human placental microsomes by 13-retro-antiprogestins.
Topics: Aromatase Inhibitors; Estrenes; Estrone; Female; Gonanes; Humans; Microsomes; Mifepristone; Placenta; Pregnancy; Progestins | 1995 |
Progesterone receptor and the mechanism of action of progesterone antagonists.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; DNA-Binding Proteins; Estrenes; Gonanes; Humans; In Vitro Techniques; Mifepristone; Progesterone; Promegestone; Protein Binding; Protein Conformation; Receptors, Progesterone; Signal Transduction; Transcription Factors; Transcription, Genetic | 1995 |